Artwork

Content provided by Cochrane. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Cochrane or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

What are the benefits and risks of different corticosteroid treatments delivered intravenously for the prevention of bronchopulmonary dysplasia in infants born prematurely?

4:27
 
Share
 

Manage episode 410587503 series 50759
Content provided by Cochrane. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Cochrane or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

The question of whether and how to treat preterm infants with postnatal corticosteroids for the management of bronchopulmonary dysplasia, which is a chronic lung problem due to prematurity, has been a neonatologist's quandary for decades. In August 2023, Cochrane Neonatal published a network meta-analysis on the use of postnatal corticosteroids for its prevention. In this podcast, Roger Soll of Cochrane Neonatal, talks with the lead author Susanne Hay, an attending neonatologist at Beth Israel Deaconess Medical Center in the US, about her team's work.

  continue reading

341 episodes

Artwork
iconShare
 
Manage episode 410587503 series 50759
Content provided by Cochrane. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Cochrane or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

The question of whether and how to treat preterm infants with postnatal corticosteroids for the management of bronchopulmonary dysplasia, which is a chronic lung problem due to prematurity, has been a neonatologist's quandary for decades. In August 2023, Cochrane Neonatal published a network meta-analysis on the use of postnatal corticosteroids for its prevention. In this podcast, Roger Soll of Cochrane Neonatal, talks with the lead author Susanne Hay, an attending neonatologist at Beth Israel Deaconess Medical Center in the US, about her team's work.

  continue reading

341 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide